Fresenius blood-loss drug gets FDA nod

12/27/2007 | Forbes

The FDA on Thursday approved Frankfurt, Germany-based Fresenius SE's blood-thickening solution Voluven for use in patients who have lost massive amounts of blood. Voluven, which has been found to be as safe as similar solutions, including B. Braun Medical's Hespan, works by increasing the volume of red blood cells and plasma.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN